Nivolumab-induced organizing pneumonia in a melanoma patient

被引:37
|
作者
Sano, Tasuku [1 ]
Uhara, Hisashi [1 ]
Mikoshiba, Yasutomo [1 ]
Kobayashi, Aya [1 ]
Uchiyama, Ryuhei [1 ]
Tateishi, Kazunari [2 ]
Yamamoto, Hiroshi [2 ]
Okuyama, Ryuhei [1 ]
机构
[1] Shinshu Univ, Sch Med, Dept Dermatol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan
[2] Shinshu Univ, Sch Med, Dept Internal Med 1, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan
关键词
melanoma; nivolumab; drug induced lung disease; PD-1; UNTREATED MELANOMA; IPILIMUMAB; SAFETY; ANTI-PD-1;
D O I
10.1093/jjco/hyv199
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report the case of a 70-year-old woman with vaginal melanoma and multiple metastases in the lung. After the third dose of nivolumab, decreased room-air resting arterial oxygen saturation with bilateral basal fine crackles on auscultation developed despite the absence of respiratory symptoms. Computed tomography showed ground-glass opacities with airspace consolidations scattered with a peculiar distribution, and most were observed around the existing metastatic tumors in the lung. From the 42nd day to the 56th day after the last administration of nivolumab, she received dexamethasone 1-2 mg/body for the prevention of adverse events after stereotactic radiation for brain metastasis. At 3 months after the last administration of nivolumab, a computed tomography scan revealed improvement of the pneumonia and a decreased size and number of metastatic lesions in the lung, although some lesions showed enlargement. Further examination is needed to clarify the relationship between the pattern of pneumonia after Nivo therapy and clinical effects.
引用
收藏
页码:270 / 272
页数:3
相关论文
共 50 条
  • [21] Late onset of nivolumab-induced severe gastroduodenitis and cholangitis in a patient with stage IV melanoma
    Calugareanu, Andreea
    Rompteaux, Pierre
    Bohelay, Gerome
    Goldfarb, Lucas
    Barrau, Vincent
    Cucherousset, Nahla
    Heidelberger, Valentine
    Nault, Jean-Charles
    Ziol, Marianne
    Caux, Frederic
    Maubec, Eve
    [J]. IMMUNOTHERAPY, 2019, 11 (12) : 1005 - 1013
  • [22] No recurrence of nivolumab-induced idiopathic thrombocytopenic purpura in a metastatic melanoma patient switched to ipilimumab
    Riko Takimoto
    Atsushi Otsuka
    Yo Kaku
    Tetsuya Honda
    Kenji Kabashima
    [J]. European Journal of Dermatology, 2018, 28 : 84 - 85
  • [23] Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patient
    Pillonel, Vincent
    Dunet, Vincent
    Hottinger, Andreas F.
    Berthod, Gregoire
    Schiappacasse, Luis
    Peters, Solange
    Michielin, Olivier
    Aedo-Lopez, Veronica
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [24] No recurrence of nivolumab-induced idiopathic thrombocytopenic purpura in a metastatic melanoma patient switched to ipilimumab
    Takimoto, Riko
    Otsuka, Atsushi
    Kaku, Yo
    Honda, Tetsuya
    Kabashima, Kenji
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2018, 28 (01) : 84 - 85
  • [25] Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic mucosal melanoma
    Goff, Catherine B.
    Plaxe, Steven C.
    White, Wendy
    Dasanu, Constantin A.
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (05) : 1259 - 1263
  • [26] Nivolumab-Induced Polymyalgia Rheumatica in a Patient with Lung Adenocarcinoma
    Kita, Toshiyuki
    Araya, Tomoyuki
    Sakai, Tamami
    Uchida, Yuka
    Matsuoka, Hiroki
    Kasahara, Kazuo
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2021, 362 (03): : 321 - 323
  • [27] Nivolumab-induced severe pancytopenia in a patient with lung adenocarcinoma
    Tokumo, Kentaro
    Masuda, Takeshi
    Miyama, Takahiko
    Miura, Shinichiro
    Yamaguchi, Kakuhiro
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Nakashima, Taku
    Miyamoto, Shintaro
    Yoshida, Takashi
    Iwamoto, Hiroshi
    Fujitaka, Kazunori
    Hamada, Hironobu
    Hattori, Noboru
    [J]. LUNG CANCER, 2018, 119 : 21 - 24
  • [28] Nivolumab-Induced Pneumonitis
    Chugh, Karan
    Jatwani, Karan
    Bhanot, Ravinder
    Dubaybo, Basim
    [J]. CHEST, 2016, 150 (04) : 678A - 678A
  • [29] Nivolumab-induced sialadenitis
    Takahashi, Saeko
    Chieko, Xu
    Sakai, Tetsuya
    Hirose, Shigemichi
    Nakamura, Morio
    [J]. RESPIROLOGY CASE REPORTS, 2018, 6 (05):
  • [30] Nivolumab-induced adrenalitis
    Iqbal, Iqra
    Khan, Muhammad Atique Alam
    Ullah, Waqas
    Nabwani, Dina
    [J]. BMJ CASE REPORTS, 2019, 12 (11)